<br />Tallinn- January 30- 2008 - The investment group Ambient SoundInvestments (ASI) has acquired a stake in EGeen - a clinicalresearch company that conducts clinical trials of drugs forAmerican and European clients.
According to an agreement between the companies- ASI is toinvest 2.6 million EEK (250-000 USD) in EGeen. EGeen represents thesecond medical company in ASI-s portfolio besides the biotechnologyenterprise Celecure.